Financial News
Vaxcyte Inc (NQ: PCVX )
75.31
+0.37
(+0.49%)
Streaming Delayed Price
Updated: 10:29 AM EDT, Jun 24, 2024
Add to My Watchlist
All News about Vaxcyte Inc
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
From Vaxcyte, Inc.
Via GlobeNewswire
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
![](/next-assets/images/schema-image-default.png)
Preview: Vaxcyte's Earnings
February 24, 2023
Via Benzinga
Expert Ratings for Vaxcyte
January 03, 2023
Via Benzinga
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/20/screenshot_2023-04-20_at_5.35.53_pm.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
Vaxcyte Announces Pricing of $500 Million Public Offering
April 19, 2023
From Vaxcyte, Inc.
Via GlobeNewswire
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://www.marketbeat.com/logos/articles/med_20230418073359_still-50-upside-to-go-wall-street-is-getting-vaxcy.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/17/screen_shot_2023-04-17_at_4.15.01_pm.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/04/17/satsuma_pharmaceuticals_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
Vaxcyte to Report Fourth Quarter and Full Year 2022 Financial Results on February 27, 2023
February 16, 2023
From Vaxcyte, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image_130.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
Vaxcyte to Present at the SVB Securities Global Biopharma Conference
February 07, 2023
From Vaxcyte, Inc.
Via GlobeNewswire
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/03/pcvx_logo_light__e4f9b517ec1b7d43d4ea190d0bdbcf0e.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/03/image-tesla4.jpg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 16, 2022
December 16, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
From Vaxcyte, Inc.
Via GlobeNewswire
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_30794.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2022
December 15, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_29750.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For November 17, 2022
November 17, 2022
Via Benzinga
![](https://ml.globenewswire.com/media/7c0fe2be-057f-4a85-b783-cb22e2d6f94d/small/new-logo-with-tagline-jpg.jpg)
Vaxcyte to Present at Upcoming Investor Conferences
November 03, 2022
From Vaxcyte, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.